On June 28, 2019 while attending the annual Drug Information Association (DIA) meeting in San Diego, FOCM was busy expanding its network. All new membership ceremonies are significant and strict adherence to protocol is (almost) always followed. This particular ceremony included a new addition to the protocol. FOCM is pleased to announce that Jodi Andrews, Founder and Co-CEO of Pro-Trials Research received her membership card.
This ceremony took place on the exhibit hall floor. What was added to the procedure for this ceremony was a shot of bourbon prior to the handshake, card presentation and photo. Later, a small pour of Fireball was distributed to the new member.
The DIA 2019 Call-for-Abstracts is now OPEN!! DIA 2019 will be in San Diego, getting an abstract approved is a great way to get to attend. The registration fee is significantly reduced for those who present content. At the site is also the abstract guidelines and categories.
The submission period is open from August 1 – September 12.
FOCM was busy before and at the DIA convention in Boston in June. FOCM along with Zymewire, Investigator Support Services, Kwipped and DataMatrix sponsored the 2nd annual Sunday night networking event before DIA exhibits opened. In the exhibit hall, FOCM gave its seal of approval to several vendors, assisTek being one. Unfortunately, the Arizona State Sun Devil hand sign snuck into the picture. In the shadow on the table, it appears to be a weapon of some kind.
At the recent annual Drug Information Association (DIA) meeting held in Boston last month, two outstanding individuals completed the grueling probationary period, thorough background checks and initiation process. Please join me in welcoming Andrew Suri and Megan Carson to FOCM. As others who have received their membership cards, the ceremony itself can be emotionally draining. This was no exception, the sheer joy on their faces tells the story.
Andrew is Director of Business Development for Clinogix. Megan is Assistant Project Manager at assisTek.